Sero-prevalence of Hepatitis B virus and plasmodium co-infection profile among patients in Wukari and Environs, North East Nigeria

Edobor Peter Kenneth Imarenezor *, Onolunosen Abel Abhadionmhen, Sunday Danya, Joyce Briska and Paula Paul Shinggu

Tropical Diseases Unit, Department of Microbiology, Faculty of Pure and Applied Sciences, Federal University Wukari, Taraba State, Nigeria.
 
Research Article
International Journal of Science and Research Archive, 2021, 03(01), 114–123.
Article DOI: 10.30574/ijsra.2021.3.1.0120
Publication history: 
Received on 12 July 2021; revised on 19 August 2021; accepted on 21 August 2021
 
Abstract: 
Hepatitis B virus and plasmodium co-infection is of an increase in developing countries as a result of lack of proper diagnosis leading to increased morbidity. This study was to determine the sero-prevalence of Hepatitis B Virus and Plasmodium co-infection profile among patients in Wukari and environs. Seventy (70) subjects’ with the age range of between 0 to 80 years participated and standard microbiological techniques were observed in this study. The results obtained showed 34 (48.6%) were males and 36 (51.4%) were females. Four (5.7%) participants were sero-positive for HBsAg. HBsAb, HBcAb, HBeAg and HBeAb while 66 were not detected positive. The Male with 5.9% participants were sero-positive while 5.6% of the female participants were sero-positive. 20 (28.6%) of the participants were sero-positive for malaria. This comprises of 7 males and 13 females. 20.6% of the males were sero-positive while 36.1% of the females were sero-positive. The distribution of parasitaemia by gender across the participants showed that 24 (34.3%) had plasmodium parasitaemia, out of which 9 were males and 15 were females. 26.5% of the males and 41.7% of the females had plasmodium parasitaemia. There was no co-infection of Hepatitis B virus and malaria, despite both having prevalence of 5.7% and 34.3% respectively. The research on its own has shown that in order to reduce HBV and plasmodium co-infection, mass immunization of adults and antiviral drugs should be provided for those that are infected, while HBV and plasmodium co-infections screening programs should be instituted in all levels of institutions in the country to reduce the prevalence rate and level of transmission of the hepatitis virus. This study also has added to the puddle of knowledge already available in this area of research.
 
Keywords: 
Hepatitis B Virus; Patients; Plasmodium; Wukari, Sero-prevalence
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0